Clinical Trial Update: An Open-label, Dose-finding, Phase I Study to Evaluate the Safety and Immunogenicity of a Bivalent Klebsiella Pneumoniae Vaccine (CHO-V08) in Healthy Adults [Phase 1]

View source ↗

Summary

An open-label Phase I dose-finding trial to evaluate the safety and immunogenicity of CHO-V08, a bivalent Klebsiella pneumoniae vaccine, in healthy adults; recr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Klebsiella Pneumoniae Infection

Drugs mentioned

• CHO-V08

Snippet

Sponsor: Cho Pharma Inc. | Conditions: Klebsiella Pneumoniae Infection, Vaccine | Phase 1 | Status: RECRUITING